Invesco Ltd. Liquidia Corp Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Liquidia Corp stock. As of the latest transaction made, Invesco Ltd. holds 24,917 shares of LQDA stock, worth $274,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,917

Previous 459,402 94.58%

Holding current value

$274,336

Previous $6.78 Million 95.59%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$11.96 - $15.71 $5.2 Million - $6.83 Million	-434,485 Reduced 94.58%	24,917 $299,000
Q1 2024 May 14, 2024	BUY	$11.35 - $16.73 $4.76 Million - $7.02 Million	419,378 Added 1047.82%	459,402 $6.78 Million
Q4 2023 Feb 12, 2024	BUY	$5.77 - $12.19 $33,304 - $70,360	5,772 Added 16.85%	40,024 $481,000
Q3 2023 Nov 13, 2023	SELL	$6.27 - $8.15 $1.68 Million - $2.19 Million	-268,156 Reduced 88.67%	34,252 $217,000
Q2 2023 Aug 11, 2023	BUY	$6.63 - $9.9 $12,325 - $18,404	1,859 Added 0.62%	302,408 $2.37 Million
Q1 2023 May 12, 2023	BUY	$5.72 - $7.91 $1.56 Million - $2.16 Million	273,130 Added 996.13%	300,549 $2.08 Million
Q4 2022 Feb 13, 2023	BUY	$4.68 - $6.54 $15,556 - $21,738	3,324 Added 13.8%	27,419 $174,000
Q3 2022 Nov 14, 2022	SELL	$3.73 - $8.39 $23,573 - $53,024	-6,320 Reduced 20.78%	24,095 $131,000
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $766,024 - $1.72 Million	-227,307 Reduced 88.2%	30,415 $133,000
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $1.32 Million - $1.9 Million	257,722 New	257,722 $1.85 Million
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $2.64 Million - $5.88 Million	-1,015,535 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.34 - $8.28 $392,388 - $748,611	-90,412 Reduced 8.18%	1,015,535 $5 Million
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $5.37 Million - $12.7 Million	1,105,947 New	1,105,947 $9.31 Million

Others Institutions Holding LQDA

# of Institutions

163

Shares Held

36M

Call Options Held

1.79M

Put Options Held

380K

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account